Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Usana Health Sciences (USNA) over the last 14 years, with Q3 2025 value amounting to $18.6 million.

  • Usana Health Sciences' Shares Outstanding (Weighted Average) fell 256.44% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year decrease of 256.44%. This contributed to the annual value of $19.1 million for FY2024, which is 76.36% down from last year.
  • According to the latest figures from Q3 2025, Usana Health Sciences' Shares Outstanding (Weighted Average) is $18.6 million, which was down 256.44% from $18.8 million recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Shares Outstanding (Weighted Average) peaked at $21.2 million during Q1 2021, and registered a low of $18.6 million during Q3 2025.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $19.4 million, with a median of $19.3 million in 2022.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 542.05% in 2022, then increased by 19.71% in 2023.
  • Over the past 5 years, Usana Health Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $20.4 million in 2021, then dropped by 5.46% to $19.3 million in 2022, then fell by 0.02% to $19.2 million in 2023, then decreased by 0.76% to $19.1 million in 2024, then fell by 2.54% to $18.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $18.6 million in Q3 2025, compared to $18.8 million in Q2 2025 and $19.0 million in Q1 2025.